Evidence map›Paper›PMID 42222080›Full record

ArticleFrontiers in endocrinology2026

Association of organ dysfunction trajectories and major adverse cardiovascular events using clinical obesity in UK Biobank.

Yohwan Lim, Su Kyoung Lee

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yohwan LimGochang-gun Public Health Center, Ministry of Health and Welfare, Go-Chang, Republic of Korea.
Su Kyoung LeeDepartment of Healthcare Management, College of Health and Medical Science, Daejeon University, Daejeon, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Obesity is a major modifiable risk factor for cardiovascular disease. We evaluated whether multi-organ dysfunction trajectories for major adverse cardiovascular events (MACE) using clinically defined obesity classification improves risk discrimination compared with BMI-based categories. Methods: We analyzed 457,675 UK Biobank participants. BMI-based categories were defined using ethnicity-specific thresholds. Clinically defined obesity was classified as no, preclinical (excess adiposity without organ dysfunction), or clinical obesity (excess adiposity with ≥1 obesity-related organ dysfunction). Organ dysfunction trajectories were constructed over consecutive 2-year periods beginning 2 years after baseline: (1) status (no, period 1 only, period 2 only, persistent organ dysfunctions) and (2) change (no, increase, decrease, persistent organ dysfunctions). Incident MACE was defined as a composite of ischemic heart disease, stroke, and fatal cardiovascular disease. Participants were followed until the first occurrence of incident MACE, death, 10 years after the index date, or the end of follow up, whichever came first. Cox models estimated adjusted hazard ratio (aHR). Results: Across status trajectories, MACE risk increased in a graded response from no dysfunction to persistent dysfunction under both obesity definitions. Within trajectories, clinical obesity showed the highest risk under the clinically defined definition (clinical vs no obesity: no dysfunction aHR 2.03, 95% CI 1.96-2.11; persistent dysfunction aHR 1.61, 95% CI 1.30-2.01), whereas underweight showed the highest risk under BMI categories (underweight vs normal: no dysfunction aHR 1.83, 95% CI 1.62-2.07; persistent dysfunction aHR 2.19, 95% CI 1.32-3.63). The 10-year cumulative incidence of MACE within persistent dysfunction increased monotonically across clinically defined categories (~24% in clinical obesity), while BMI-based categories peaked in the overweight (~20%). Conclusions: Multi-organ dysfunction trajectories were strongly associated with incident MACE, having persistent dysfunction as the highest risk. Clinically defined obesity provided more monotonic, graded risk across trajectories than BMI, which were susceptible to reverse causation. Incorporating clinical obesity definitions with longitudinal dysfunction assessment may improve cardiovascular risk stratification.

Indexed as

Cardiovascular DiseasesObesityAdiposityAgedBiological Specimen BanksBody Mass IndexFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedRisk FactorsUK BiobankUnited Kingdombody mass indexclinical obesitymajor adverse cardiovascular eventsobesitytrajectory

Identifiers

PMID42222080
PMCPMC13215929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.